These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37724205)

  • 1. Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease.
    Asatullina Z; Sineglazova AV
    Cureus; 2023 Aug; 15(8):e43711. PubMed ID: 37724205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.
    Sonaglioni A; Cerini F; Cerrone A; Argiento L; Nicolosi GL; Rigamonti E; Lombardo M; Rumi MG; Viganò M
    Intern Emerg Med; 2022 Aug; 17(5):1425-1438. PubMed ID: 35302179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant Association between Subclinical Left Cardiac Dysfunction and Liver Stiffness in Metabolic Syndrome Patients with Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease.
    Apostu A; Malita D; Arnautu SF; Tomescu MC; Gaiță D; Popescu A; Mare R; Gidea R; Arnautu DA
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837528
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension.
    Catena C; Brosolo G; Da Porto A; Donnini D; Bulfone L; Vacca A; Soardo G; Sechi LA
    Front Cardiovasc Med; 2022; 9():1030968. PubMed ID: 36312275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial.
    Attaran F; Emami S; Sohrabi M; Malek M; Ajdarkosh H; Khoonsari M; Ismail-Beigi F; Khamseh ME
    BMC Gastroenterol; 2023 Sep; 23(1):327. PubMed ID: 37742004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
    Parvanescu T; Vitel A; Sporea I; Mare R; Buz B; Bordejevic DA; Tomescu MC; Arnautu SF; Morariu VI; Citu IM
    Diabetes Metab Syndr Obes; 2021; 14():1535-1545. PubMed ID: 33859484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study.
    VanWagner LB; Wilcox JE; Ning H; Lewis CE; Carr JJ; Rinella ME; Shah SJ; Lima JAC; Lloyd-Jones DM
    J Am Heart Assoc; 2020 Feb; 9(4):e014279. PubMed ID: 32067588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography.
    Chang W; Wang Y; Sun L; Yu D; Li Y; Li G
    Echocardiography; 2019 Jul; 36(7):1290-1297. PubMed ID: 31206765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.
    Bonapace S; Perseghin G; Molon G; Canali G; Bertolini L; Zoppini G; Barbieri E; Targher G
    Diabetes Care; 2012 Feb; 35(2):389-95. PubMed ID: 22210573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
    Chung GE; Lee JH; Lee H; Kim MK; Yim JY; Choi SY; Kim YJ; Yoon JH; Kim D
    Atherosclerosis; 2018 May; 272():137-144. PubMed ID: 29604480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Management of Cirrhotic Cardiomyopathy.
    Kaur H; Premkumar M
    J Clin Exp Hepatol; 2022; 12(1):186-199. PubMed ID: 35068798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure.
    Misan IA; Arisheva OS; Garmash IV; Cabello FR; Kobalava ZD
    Kardiologiia; 2023 Dec; 63(12):72-76. PubMed ID: 38156493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease.
    Sert A; Aypar E; Pirgon O; Yilmaz H; Odabas D; Tolu I
    Am J Cardiol; 2013 Aug; 112(3):436-43. PubMed ID: 23642511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
    EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status.
    Jiang W; Liu Z; Liu S; Du T
    Front Endocrinol (Lausanne); 2023; 14():1183075. PubMed ID: 37941902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Non- alcoholic Fatty Liver Disease and Left Ventricular Diastolic Dysfunction in Patients of Type 2 Diabetes.
    Saluja M; Kumar K; Swami YK; Meena SR; Goyal S
    J Assoc Physicians India; 2019 Aug; 67(8):20-24. PubMed ID: 31562711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.